Terms: = Breast cancer AND RARA, RAR, 5914, ENSG00000131759, NR1B1 AND Treatment
117 results:
1. 5-Azacytidine- and retinoic-acid-induced reprogramming of DCCs into dormancy suppresses metastasis via restored TGF-β-SMAD4 signaling.
Singh DK; Carcamo S; Farias EF; Hasson D; Zheng W; Sun D; Huang X; Cheung J; Nobre AR; Kale N; Sosa MS; Bernstein E; Aguirre-Ghiso JA
Cell Rep; 2023 Jun; 42(6):112560. PubMed ID: 37267946
[TBL] [Abstract] [Full Text] [Related]
2. The Role of Apoptotic Genes and Protein-Protein Interactions in Triple-negative breast cancer.
Adinew GM; Messeha S; Taka E; Ahmed SA; Soliman KFA
Cancer Genomics Proteomics; 2023; 20(3):247-272. PubMed ID: 37093683
[TBL] [Abstract] [Full Text] [Related]
3. Targeting the Retinoic Acid Pathway to Eradicate cancer Stem Cells.
Brown G
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768694
[TBL] [Abstract] [Full Text] [Related]
4. Combination treatment of Retinoic Acid Plus Focal Adhesion Kinase Inhibitor Prevents Tumor Growth and breast cancer Cell Metastasis.
Castro-Guijarro AC; Vanderhoeven F; Mondaca JM; Redondo AL; Zoppino FCM; Fernandez-Muñoz JM; Sanchez AM; Flamini MI
Cells; 2022 Sep; 11(19):. PubMed ID: 36230951
[TBL] [Abstract] [Full Text] [Related]
5. Increased expression of Profilin potentiates chemotherapeutic agent-mediated tumour regression.
Saurav S; Manna SK
Br J Cancer; 2022 Jun; 126(10):1410-1420. PubMed ID: 35022526
[TBL] [Abstract] [Full Text] [Related]
6. Rest activity rhythms characteristics of breast cancer women following endocrine therapy.
Martin T; Duivon M; Bessot N; Grellard JM; Emile G; Polvent S; Raoul L; Viader F; Eustache F; Joly F; Giffard B; Perrier J
Sleep; 2022 Apr; 45(4):. PubMed ID: 34624895
[TBL] [Abstract] [Full Text] [Related]
7. Rank-preserving biclustering algorithm: a case study on miRNA breast cancer.
Mandal K; Sarmah R; Bhattacharyya DK; Kalita JK; Borah B
Med Biol Eng Comput; 2021 Apr; 59(4):989-1004. PubMed ID: 33840048
[TBL] [Abstract] [Full Text] [Related]
8. A tumour suppressive relationship between mineralocorticoid and retinoic acid receptors activates a transcriptional program consistent with a reverse Warburg effect in breast cancer.
Doan TB; Cheung V; Clyne CD; Hilton HN; Eriksson N; Young MJ; Funder JW; Muscat GEO; Fuller PJ; Clarke CL; Graham JD
Breast Cancer Res; 2020 Nov; 22(1):122. PubMed ID: 33148314
[TBL] [Abstract] [Full Text] [Related]
9. Protein Kinase C Alpha (PKCα) overexpression leads to a better response to retinoid acid therapy through Retinoic Acid Receptor Beta (rarβ) activation in mammary cancer cells.
Bessone MID; Berardi DE; Cirigliano SM; Delbart DI; Peters MG; Todaro LB; Urtreger AJ
J Cancer Res Clin Oncol; 2020 Dec; 146(12):3241-3253. PubMed ID: 32865619
[TBL] [Abstract] [Full Text] [Related]
10. Clinicopathologic features of breast cancer reclassified as HER2-amplified by fluorescence in situ hybridization with alternative chromosome 17 probes.
Blanton KC; Deal AM; Kaiser-Rogers KA; Anders CK; O'Connor SM; Hertel JD; Calhoun BC
Ann Diagn Pathol; 2020 Oct; 48():151576. PubMed ID: 32805517
[TBL] [Abstract] [Full Text] [Related]
11. Fertility in female cancer survivors: a systematic review and meta-analysis.
Busnelli A; Vitagliano A; Mensi L; Acerboni S; Bulfoni A; Filippi F; Somigliana E
Reprod Biomed Online; 2020 Jul; 41(1):96-112. PubMed ID: 32456969
[TBL] [Abstract] [Full Text] [Related]
12. Characterization of therapy-related acute leukemia in hereditary breast-ovarian carcinoma patients: role of BRCA1 mutation and topoisomerase II-directed therapy.
Bagal B; Kumar R; Gaur T; Talreja V; Bonda A; Patkar N; Shetty D; Kowtal P; Subramanian PG; Gupta S; Sarin R; Hasan SK
Med Oncol; 2020 Apr; 37(5):48. PubMed ID: 32277283
[TBL] [Abstract] [Full Text] [Related]
13. Indeno[1,2,3-cd]pyrene and picene mediate actions via estrogen receptor α signaling pathway in in vitro cell systems, altering gene expression.
Böckers M; Paul NW; Efferth T
Toxicol Appl Pharmacol; 2020 Jun; 396():114995. PubMed ID: 32251684
[TBL] [Abstract] [Full Text] [Related]
14. Down-regulation of vimentin by triorganotin isothiocyanates-nuclear retinoid X receptor agonists: A proteomic approach.
Strouhalova D; Macejova D; Mosna B; Bobal P; Otevrel J; Lastovickova M; Brtko J; Bobalova J
Toxicol Lett; 2020 Jan; 318():22-29. PubMed ID: 31634547
[TBL] [Abstract] [Full Text] [Related]
15. Concurrent targeting of BMI1 and CDK4/6 abrogates tumor growth in vitro and in vivo.
Elango R; Vishnubalaji R; Manikandan M; Binhamdan SI; Siyal AA; Alshawakir YA; Alfayez M; Aldahmash A; Alajez NM
Sci Rep; 2019 Sep; 9(1):13696. PubMed ID: 31548560
[TBL] [Abstract] [Full Text] [Related]
16. Assessing Autophagy During Retinoid treatment of breast cancer Cells.
Parejo S; Tschan MP; Muraro MG; Garattini E; Spagnoli GC; Schläfli AM
Methods Mol Biol; 2019; 2019():237-256. PubMed ID: 31359401
[TBL] [Abstract] [Full Text] [Related]
17. Methods to Generate an Array of Novel Rexinoids by SAR on a Potent Retinoid X Receptor Agonist: A Case Study with NEt-TMN.
Wagner CE; Jurutka PW
Methods Mol Biol; 2019; 2019():109-121. PubMed ID: 31359392
[TBL] [Abstract] [Full Text] [Related]
18. HiFreSP: A novel high-frequency sub-pathway mining approach to identify robust prognostic gene signatures.
Li M; Zhao J; Li X; Chen Y; Feng C; Qian F; Liu Y; Zhang J; He J; Ai B; Ning Z; Liu W; Bai X; Han X; Wu Z; Xu X; Tang Z; Pan Q; Xu L; Li C; Wang Q; Li E
Brief Bioinform; 2020 Jul; 21(4):1411-1424. PubMed ID: 31350847
[TBL] [Abstract] [Full Text] [Related]
19. Novel insights into the combined effect of triorganotin compounds and all-trans retinoic acid on expression of selected proteins associated with tumor progression in breast cancer cell line MDA-MB-231: Proteomic approach.
Strouhalova D; Toporova L; Lastovickova M; Macejova D; Bobalova J; Brtko J
Gen Physiol Biophys; 2019 Mar; 38(2):135-144. PubMed ID: 30806631
[TBL] [Abstract] [Full Text] [Related]
20. S100A3 a partner protein regulating the stability/activity of rarα and PML-rarα in cellular models of breast/lung cancer and acute myeloid leukemia.
Gianni M; Terao M; Kurosaki M; Paroni G; Brunelli L; Pastorelli R; Zanetti A; Lupi M; Acquavita A; Bolis M; Fratelli M; Rochette-Egly C; Garattini E
Oncogene; 2019 Apr; 38(14):2482-2500. PubMed ID: 30532072
[TBL] [Abstract] [Full Text] [Related]
[Next]
